Roche torch­es a moun­tain of biobucks, sweep­ing out a ros­ter of drugs in the lat­est pipeline cleanup

While Roche $RHH­BY post­ed its Q3 up­date on the num­bers, high­light­ing the im­por­tance of its new block­busters in re­plac­ing some ag­ing fran­chis­es, the R&D group …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.